- Home
- NIU vs ALDX Comparison
NIU vs ALDX Comparison
Compare NIU & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- ALDX
- Stock Information
- Founded
- NIU 2014
- ALDX 2004
- Country
- NIU China
- ALDX United States
- Employees
- NIU N/A
- ALDX N/A
- Industry
- NIU Auto Manufacturing
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- ALDX Health Care
- Exchange
- NIU Nasdaq
- ALDX Nasdaq
- Market Cap
- NIU 275.6M
- ALDX 314.6M
- IPO Year
- NIU 2018
- ALDX 2014
- Fundamental
- Price
- NIU $4.43
- ALDX $5.25
- Analyst Decision
- NIU
- ALDX Strong Buy
- Analyst Count
- NIU 0
- ALDX 2
- Target Price
- NIU N/A
- ALDX $9.50
- AVG Volume (30 Days)
- NIU 879.3K
- ALDX 623.6K
- Earning Date
- NIU 11-17-2025
- ALDX 11-06-2025
- Dividend Yield
- NIU N/A
- ALDX N/A
- EPS Growth
- NIU N/A
- ALDX N/A
- EPS
- NIU N/A
- ALDX N/A
- Revenue
- NIU $527,760,629.00
- ALDX N/A
- Revenue This Year
- NIU $41.32
- ALDX N/A
- Revenue Next Year
- NIU $24.38
- ALDX $63.48
- P/E Ratio
- NIU N/A
- ALDX N/A
- Revenue Growth
- NIU 32.62
- ALDX N/A
- 52 Week Low
- NIU $1.66
- ALDX $1.14
- 52 Week High
- NIU $5.67
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- NIU 48.07
- ALDX 47.33
- Support Level
- NIU $4.07
- ALDX $5.06
- Resistance Level
- NIU $4.66
- ALDX $5.55
- Average True Range (ATR)
- NIU 0.30
- ALDX 0.27
- MACD
- NIU -0.07
- ALDX -0.03
- Stochastic Oscillator
- NIU 21.70
- ALDX 25.38
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.